Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Latest News

  • Article

    Weighing Benefits and Risks of Indefinite Anticoagulation in First Unprovoked VTE

    October 2, 2023

    Clinical question: Is indefinite anticoagulation beneficial for patients with a first unprovoked venous thromboembolism (VTE) after initial treatment? Dr. Sheikh Background: VTE is a chronic,...

  • Article

    Pitavastatin and Cardiovascular Disease Prevention in HIV Patients

    October 2, 2023

    Clinical question: Does pitavastatin reduce the risk of cardiovascular disease in human immunodeficiency virus (HIV)-infected individuals? Dr. Sheikh Background: Individuals with HIV infection...

  • Article

    No Difference Between Liberal Versus Strict Perioperative BP Management in Non-cardiac Surgery

    October 2, 2023

    Clinical question: In patients on antihypertensive medications (AHMs) such as angiotensin-converting-enzyme inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs) undergoing inpatient...

  • Article

    DAPT Non-inferior to Alteplase for Minor AIS

    October 2, 2023

    Clinical question: Is dual antiplatelet therapy (DAPT) non-inferior to intravenous (IV) thrombolysis in patients with minor non-disabling acute ischemic strokes (AIS)? Dr....

  • Article

    Intensive BP Control with PO or IV Harmful in Hospitalized Older Adults

    October 2, 2023

    Clinical question: How do clinical outcomes compare between patients with asymptomatic hypertension treated intensively versus not while hospitalized? Dr. Richardson Background: While the...

  • Article

    Delayed Antibiotics in Suspected Sepsis Increase Shock Risk and Mortality

    October 2, 2023

    Clinical question: Does the time to first antibiotics affect the risk of progression to septic shock? Dr. Richardson Background: The Surviving Sepsis Campaign emphasized early infection...

  • Article

    Coding Corner: HF and Physician Underbilling—Two Common Conditions

    October 2, 2023

    Coding Corner, a new section that will appear periodically in The Hospitalist, features common coding and/or billing issues hospitalists regularly face. If you have suggestions for upcoming coding...

  • Article

    P2Y12 Inhibitor Monotherapy After 1-3 Months of DAPT Reduces Major Bleeding Risk Without Increasing Ischemic Risk After Complex PCI

    October 2, 2023

    Clinical question: Does P2Y12 inhibitor monotherapy after one to three months of dual antiplatelet therapy (DAPT) improve clinical decrease in major bleeding risk without increasing ischemic risk in...

  • Article

    Waves

    September 8, 2023

    There we go again. I’m sorry honey. I don’t know why it starts beeping suddenly. I hate to keep bothering you all night. Well, to be honest, my breathing has been a little shallow tonight. Yes,...

  • Article

    Movers and Shakers September 2023

    September 1, 2023

    Dr. Mgbokikwe Nkemdilim Mgbojikwe, MD, has joined Fox Chase Cancer Center, Philadelphia, as associate chief medical officer; she will also serve as an associate professor and hospitalist in the...

Previous1 … 38 39 40 41 42 … 358Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences